News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
41,212 Results
Type
Article (2429)
Company Profile (14)
Press Release (38769)
Section
Business (11537)
Career Advice (18)
Deals (1608)
Drug Delivery (2)
Drug Development (9938)
Employer Resources (4)
FDA (642)
Job Trends (1098)
News (22204)
Policy (1289)
Tag
2024 BioForest Digital (1)
2024 Bio NC Digital (1)
2024 Biotech Beach Digital (1)
2024 Genetown Digital (1)
2024 Lone Star Bio Digital (2)
2024 Pharm Country Digital (1)
Academia (179)
Adcomms (1)
Allergies (48)
Alliances (3335)
ALS (9)
Alzheimer's disease (74)
Antibody-drug conjugate (ADC) (23)
Approvals (650)
Artificial intelligence (24)
Autoimmune disease (1)
Automation (1)
Bankruptcy (18)
Best Places to Work (1037)
Biosimilars (7)
Biotechnology (12)
Bladder cancer (29)
Brain cancer (7)
Breast cancer (62)
Cancer (669)
Cardiovascular disease (3)
Career advice (17)
CAR-T (59)
Cell therapy (122)
Cervical cancer (6)
Clinical research (7913)
Collaboration (93)
Compensation (28)
Complete response letters (1)
COVID-19 (149)
CRISPR (1)
C-suite (21)
Data (314)
Diabetes (8)
Diagnostics (274)
Drug discovery (10)
Duchenne muscular dystrophy (3)
Earnings (4328)
Employer branding (1)
Employer resources (4)
Events (9299)
Executive appointments (48)
FDA (728)
Frontotemporal dementia (1)
Funding (62)
Gene editing (5)
Gene therapy (21)
GLP-1 (28)
Government (168)
Grass and pollen (2)
Guidances (2)
Healthcare (1595)
IgA nephropathy (2)
Immunology and inflammation (15)
Indications (6)
Infectious disease (160)
Inflammatory bowel disease (7)
Influenza (4)
Intellectual property (9)
Interviews (3)
IPO (1042)
IRA (1)
Job creations (103)
Job search strategy (16)
Kidney cancer (1)
Labor market (1)
Layoffs (21)
Legal (118)
Liver cancer (24)
Lung cancer (105)
Lymphoma (37)
Management (2)
Manufacturing (14)
MASH (2)
Medical device (110)
Medtech (110)
Mergers & acquisitions (597)
Metabolic disorders (14)
Multiple sclerosis (7)
Neurodegenerative disease (5)
Neuroscience (100)
NextGen: Class of 2025 (343)
Non-profit (218)
Northern California (221)
Obesity (2)
Opinion (16)
Ovarian cancer (28)
Pain (2)
Pancreatic cancer (14)
Parkinson's disease (3)
Patents (17)
Patient recruitment (18)
Peanut (38)
People (3578)
Pharmaceutical (2)
Phase I (3564)
Phase II (3597)
Phase III (2081)
Pipeline (145)
Podcasts (2)
Policy (3)
Postmarket research (82)
Preclinical (1285)
Press Release (15)
Prostate cancer (15)
Radiopharmaceuticals (13)
Rare diseases (5)
Real estate (188)
Recruiting (1)
Regulatory (1157)
Reports (5)
Research institute (339)
Resumes & cover letters (1)
RSV (1)
Schizophrenia (1)
Series A (10)
Series B (4)
Sickle cell disease (1)
Southern California (265)
Spinal muscular atrophy (1)
Sponsored (3)
Startups (210)
Stomach cancer (2)
Supply chain (2)
The Weekly (2)
United States (2072)
Vaccines (67)
Venture capitalists (4)
Weight loss (2)
Women's health (2)
Date
Today (21)
Last 7 days (88)
Last 30 days (299)
Last 365 days (3633)
2025 (766)
2024 (3801)
2023 (4116)
2022 (4846)
2021 (4878)
2020 (4230)
2019 (3271)
2018 (2421)
2017 (2881)
2016 (2367)
2015 (2712)
2014 (1510)
2013 (648)
2012 (547)
2011 (458)
2010 (335)
Location
Africa (19)
Alabama (3)
Arizona (10)
Asia (3150)
Australia (598)
California (574)
Canada (172)
China (107)
Colorado (20)
Connecticut (10)
Delaware (18)
Europe (7521)
Florida (85)
Georgia (13)
Idaho (6)
Illinois (27)
India (3)
Indiana (5)
Iowa (1)
Japan (10)
Kansas (12)
Kentucky (1)
Maine (2)
Maryland (118)
Massachusetts (346)
Michigan (5)
Minnesota (4)
Missouri (7)
Montana (8)
New Jersey (269)
New Mexico (1)
New York (185)
North Carolina (34)
North Dakota (6)
Northern California (221)
Ohio (3)
Oregon (4)
Pennsylvania (130)
Rhode Island (3)
South America (26)
South Carolina (1)
Southern California (265)
Tennessee (6)
Texas (116)
Utah (2)
Virginia (17)
Washington D.C. (1)
Washington State (81)
41,212 Results for "etherna immunotherapies".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
etherna Announces Strategic Multi-Target Collaboration with Dropshot Therapeutics
January 9, 2025
·
2 min read
Antonin (Tony) de Fougerolles appointed as new Chair of etherna
July 10, 2024
·
3 min read
Almirall and etherna Enter Into a Multi-Target Alliance to Develop mRNA-based Therapies in Medical Dermatology
Almirall, S.A., a global pharmaceutical company focused on medical dermatology, and etherna, an mRNA/LNP technology platform company, announced a multi-target alliance to discover and develop new mRNA-based therapies for severe skin diseases, including non-melanoma skin cancer.
December 12, 2023
·
4 min read
Business
mRNA/LNP technology platform company etherna names Bernard Sagaert as Chief Executive Officer and Marijn Dekkers as Chairman of the Board
etherna, a leading mRNA/LNP technologies company, announced that Bernard Sagaert has been confirmed-as Chief Executive Officer.
October 17, 2023
·
4 min read
Business
Steffen Helmling joins etherna as Chief Business Officer
etherna announced today that Steffen Helmling, PhD has been appointed Chief Business Officer.
June 8, 2023
·
2 min read
Press Releases
Vicero Welcomes Renowned Cancer Immunotherapy Experts to its Scientific Advisory Board
March 24, 2025
·
4 min read
Business
Money on the Move: AdvanCell, eTheRNA, Bluejay and More
Money is now flowing into promising platforms for prostate cancer from AdvanCell, mRNA therapeutics from eTheRNA, hepatitis from Bluejay and more.
August 24, 2022
·
5 min read
·
Tristan Manalac
eTheRNA Announces Relocation and Expansion of R&D Facility
eTheRNA immunotherapies NV, an mRNA technology discovery and development company with a full platform of integrated capabilities, is pleased to announce the relocation of its R&D group to a new and larger site in Gent, Belgium.
April 5, 2022
·
1 min read
eTheRNA Immunotherapies to Host Key Opinion Leader Webinar on mRNA-Lipid Nanoparticles for Cancer ImmunotherapyWednesday, March 2 at 10am ET / 3pm GMT / 4pm CET
eTheRNA immunotherapies NV (‘eTheRNA’), an mRNA technology discovery and development company with a full platform of integrated capabilities, today announced that it will host a key opinion leader (KOL) webinar on mRNA-lipid nanoparticles (LNP) for cancer immunotherapy on Wednesday, March 2, 2022 at 10am ET / 3pm GMT / 4pm CET.
February 28, 2022
·
1 min read
Press Releases
Kenox Pharmaceuticals Announces Strategic Collaboration with Lactiga to Advance Mucosal-Targeted Immunotherapy
March 10, 2025
·
2 min read
1 of 4,122
Next
